期刊文献+

田菲教授治疗乳腺癌骨转移 被引量:6

Treatment experience of Professor Tian Fei in bone metastasis of breast cancer
下载PDF
导出
摘要 田菲教授认为,乳腺癌骨转移虽病位在骨,缠绵难愈,病机多为气血瘀滞,但治疗的关键在于扶正、解毒及调畅情志。他认为,骨转移出现时乳腺癌已属晚期,癌毒久蓄耗气伤阴,所以调摄脾胃、扶助正气是治疗过程中必不可少的环节。临床多以扶正固本、解毒通络、安神定志作为要点,配合西医常规治疗方案,以期提高患者生存质量,延长其生存期。 Professor Tian Fei holds the view that the disease is located in the bone and hard to be cured, and the pathogene- sis is mostly Qi stagnation and blood stasis. The key of treatment is invigorating healthy Qi, detoxification and regulating mental states. Recuperating spleen and stomach and supporting healthy Qi are indispensable links in the process of treatment if advanced cancer appears in bone metastasis of breast cancer. With the conventional treatment programs, the primary of TCM clinical program is invigorating healthy Qi, eliminating stasis, calming the heart and tranquilizing the mind to improve the quality of life and prolong survival period.
出处 《长春中医药大学学报》 2014年第2期240-242,共3页 Journal of Changchun University of Chinese Medicine
关键词 乳腺癌 骨转移 气滞血瘀 田菲 breast cancer bone metastasis Qi-stagnancy and blood stasis Tian fei
  • 相关文献

参考文献6

二级参考文献28

  • 1楼映,唐汉钧.唐汉钧治疗乳腺癌术后经验[J].辽宁中医杂志,2005,32(3):180-182. 被引量:6
  • 2张明.陆德铭教授运用益气养阴法的临床经验[J].中西医结合学报,2005,3(2):141-143. 被引量:6
  • 3Clohisy DR, Mantyh PW. Bone cancer pain [ J]. Cancer, 2003,97 (3 Suppl) : 866-873. 被引量:1
  • 4Rosen IS, Gordon DH, Dugan WJ. et al. Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion[ J ]. Cancer, 2004,100( 1 ) : 36-43. 被引量:1
  • 5Portenoy RK, Lesage P. Management of cancer pain [ J ]. Lancet, 1999,353(9165) : 1695-1700. 被引量:1
  • 6Medhurst SJ,Walker K,Bowes M.et al.A rat model of bone cancer pain[J]. Pain,2002,96(1-2) : 129-140. 被引量:1
  • 7Walker K, Medhurst SJ, Kidd BL. et al. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain[ J]. Pain, 2002,100(3) : 219-229. 被引量:1
  • 8Roudier MP, Bain SD, Dougall WC. Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histo.pathology of bone cancer in rats[ J]. Clin Exp Metastasis. 2006,23 (3-4) : 167-175. 被引量:1
  • 9[3]Ware JE Jr,Sherbourne CD.The MOS 36-item Short-Form Health Survey(SF-36).L Conceptual framework and item selection.Med Care 1992;30(6):473-83 被引量:1
  • 10[4]Rubens,Fogelmen.Bone Metastases//Langlais F,Tomeno B.Limb Salvage.Major Reconstruction in Oncologic and Nontumoral Conditions.New York:Springer 1991:121-42 被引量:1

共引文献18

同被引文献119

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部